What is Amgen's expected EPS for Q2 2026?

Analysts expect Amgen (AMGN) to report consensus EPS of approximately $5.62 for Q2 2026. Estimates range from $4.99 to $6.28.

What revenue do analysts expect for Amgen in Q2 2026?

The consensus revenue forecast for Amgen (AMGN) in Q2 2026 is approximately $9.43B. Forecasts range from $9.1B to $9.63B.

How many analysts cover Amgen?

18 analysts contribute to the Amgen (AMGN) Q2 2026 consensus estimate.

Has Amgen beaten earnings estimates recently?

Amgen beat analyst EPS estimates in 2 of the last 2 quarters. Amgen beat revenue estimates in 2 of 2. In the most recent quarter (Q1 2026), Amgen EPS beat by 8% and revenue beat by 0.5%.

When does Amgen report Q2 2026 earnings?

Amgen (AMGN) is expected to report Q2 2026 earnings on August 4, 2026 after market close.

AMGN Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$5.62

Consensus revenue · Q2 2026

$9.4B

Analysts

Expected report

Aug 4, 2026

After close

Upcoming earnings

Locks in 12 days · AMC: Locks at 4:00 PM ET on report day

Revenue$9.4B$9.1B – $9.6B

EPS$5.62$4.99 – $6.28

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 18 analysts.

Metric	Low	Consensus	High
Revenue	$9.1B	$9.4B	$9.6B
EPS	$4.99	$5.62	$6.28
EBITDA	$4.3B	$4.3B	$4.3B
EBIT	$2.9B	$3B	$3B
Net income	$2.9B	$3.1B	$3.1B

Revenue$9.4B
EPS$5.62
EBITDA$4.3B
EBIT$3B
Net income$3.1B

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q1 2026	$8.6B	$8.6B	+0.5%	$5.15	$4.77	+8.0%
Q4 2025	$9.9B	$9.5B	+4.5%	$5.29	$4.73	+11.7%

Q1 2026+0.5%+8.0%
Q4 2025+4.5%+11.7%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Amgen (AMGN) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 4 analysts.

Low: $185.00
Consensus: $355.40
Median: $360.00
High: $427.00
Current: $366.05
Upside: -2.9%

Upside calculated vs most recent trading price of $366.05.

Analyst ratings

Consensus: Buy — based on 38 analyst ratings.

Buy 22Hold 13Sell 3

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 13, 2026	UBS	maintain	Buy	Buy
Jul 13, 2026	Guggenheim	maintain	Neutral	Neutral
Jul 8, 2026	Morgan Stanley	maintain	Equal Weight	Equal Weight
Jul 7, 2026	Truist Securities	maintain	Hold	Hold
Jul 6, 2026	Cantor Fitzgerald	maintain	Neutral	Neutral
Jun 16, 2026	Mizuho	maintain	Neutral	Neutral
Jun 10, 2026	Morgan Stanley	maintain	Equal Weight	Equal Weight
May 14, 2026	Piper Sandler	maintain	Overweight	Overweight
May 4, 2026	Guggenheim	maintain	Neutral	Neutral
May 1, 2026	Truist Securities	maintain	Hold	Hold

Jul 13, 2026UBSBuy
Jul 13, 2026GuggenheimNeutral
Jul 8, 2026Morgan StanleyEqual Weight
Jul 7, 2026Truist SecuritiesHold
Jul 6, 2026Cantor FitzgeraldNeutral
Jun 16, 2026MizuhoNeutral
Jun 10, 2026Morgan StanleyEqual Weight
May 14, 2026Piper SandlerOverweight
May 4, 2026GuggenheimNeutral
May 1, 2026Truist SecuritiesHold

Frequently asked questions

Amgen (AMGN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

AMGN Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation